UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017168
Receipt number R000019916
Scientific Title Assessment of diagnostic accuracy of dopamine receptor imaging agent "Ioflupane" for the patients with parkinsonism
Date of disclosure of the study information 2015/04/20
Last modified on 2019/04/24 17:53:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of diagnostic accuracy of dopamine receptor imaging agent "Ioflupane" for the patients with parkinsonism

Acronym

Diagnostic accuracy of Ioflupane

Scientific Title

Assessment of diagnostic accuracy of dopamine receptor imaging agent "Ioflupane" for the patients with parkinsonism

Scientific Title:Acronym

Diagnostic accuracy of Ioflupane

Region

Japan


Condition

Condition

Parkinsonism

Classification by specialty

Neurology Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the current study is to investigate the diagnostic accuracy of Ioflupane for the several diseases with parkinsonism.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diagnostic accuracy of each disease with parkinsonism

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Satisfying the following 2 conditions within 3 months.
1)Undergoing physical, laboratory and neuropsychological examinations by neurologist.
2)Undergoing Ioflupane imaging.

Key exclusion criteria

In case of declaration of non-participation.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Anri
Middle name
Last name Inaki

Organization

Kanazawa University Hospital

Division name

Department of Nuclear Medicine

Zip code

920-8641

Address

13-1, Takara-machi, Kanazawa

TEL

076-265-2333

Email

henri@nmd.m.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name Anri
Middle name
Last name Inaki

Organization

Kanazawa University Hospital

Division name

Department of Nuclear Medicine

Zip code

920-8641

Address

13-1, Takara-machi, Kanazawa

TEL

076-265-2333

Homepage URL


Email

henri@nmd.m.kanazawa-u.ac.jp


Sponsor or person

Institute

Kanazawa University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Innovative Clinical Research Center, Kanazawa University

Address

13-1, Takara-machi, Kanazawa

Tel

076-265-2090

Email

crc.irb-knz@esct.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 04 Month 01 Day

Date of IRB

2015 Year 03 Month 18 Day

Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective observational study


Management information

Registered date

2015 Year 04 Month 18 Day

Last modified on

2019 Year 04 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019916


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name